Vimarsana
Biggest News Aggregation in the World

Ambrx Board News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ambrx Board. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ambrx Board Today - Breaking & Trending Today

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP) - Vimarsana News

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP)

Published: January 9, 2024

BALA CYNWYD, Pa., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky

Source: benzinga.com
Related Topics:
United StatesBrodsky SmithMarc AckermanAmbrx Biopharma IncAxonics IncBoston Scientific CorporationHarpoon Therapeutics IncGracell Biotechnologies IncJason BrodskyAmbrx BoardGracell BoardAxonics BoardMerger AgreementHarpoon Board
Ambrx Announces Sale to Johnson & Johnson - Vimarsana News

Ambrx Announces Sale to Johnson & Johnson

Published: January 8, 2024

08.01.2024 - SAN DIEGO, Jan. 08, 2024 (GLOBE NEWSWIRE) - Ambrx Biopharma, Inc., or Ambrx (NASDAQ: AMAM), today announced that it has entered into a definitive agreement pursuant to which Johnson & Johnson will acquire all of the outstanding shares of Ambrx for ... Seite 1

Source: wallstreet-online.de
Related Topics:
Danielj OconnorAmbrx Biopharma IncChief Executive OfficerAntibody Drug ConjugateAmbrx BoardHart Scott Rodino Antitrust ImprovementsAmbrx Biopharma Incorporation ChartMbrx Biopharma Incorporation KursMbrx Biopharma Incorporation Aktie